Heck, A., Ringstad, G., Fougner, S.L., Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly (2012) Clin Endocrinol (Oxf), 77, pp. 72-78
Potorac, I., Petrossians, P., Daly, A.F., T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly (2016) Endocr Relat Cancer, 23, pp. 871-881
Coopmans, E.C., van der Lely, A.J., Schneiders, J.J., Neggers, S., Potential antitumour activity of pasireotide on pituitary tumours in acromegaly (2019) Lancet Diabetes Endocrinol, 7, pp. 425-426
Daly, A.F., Tichomirowa, M.A., Petrossians, P., Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study (2010) J Clin Endocrinol Metab, 95, pp. E373-E383
Daly, A., Rostomyan, L., Betea, D., AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients (2019) Endocr Connect, 8, pp. 367-377
Chiloiro, S., Giampietro, A., Bianchi, A., Acromegaly can be cured by first-line pasireotide treatment? (2019) Endocrine, 64, pp. 196-199
Amarawardena, W.K.M.G., Liyanarachchi, K.D., Newell-Price, J.D.C., Ross, R.J.M., Iacovazzo, D., Debono, M., Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly (2017) Endocrinol Diabetes Metab Case Rep, 2017. , pii 17-0067
Yamamoto, R., Robert Shima, K., Igawa, H., Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly (2018) Endocr J, 65, pp. 1061-1067
Bonneville, F., Rivière, L.-D., Petersenn, S., MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma: PRIMARYS post hoc analysis (2018) Eur J Endocrinol, , published online Dec 1
Potorac, I., Bonneville, J.-F., Acromegaly (2016) MRI of the pituitary gland, pp. 97-105. , Bonneville J-F Bonneville F Cattin F Nagi S Springer Cham, Switzerland
